|
PRKAA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62925228863742E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.08073574931223E-12 |
| Normal-vs-Stage2 |
1.22719999717802E-08 |
| Normal-vs-Stage3 |
7.51620987671231E-12 |
| Normal-vs-Stage4 |
2.79779532874613E-11 |
| Stage1-vs-Stage2 |
4.233800E-01 |
| Stage1-vs-Stage3 |
1.618760E-01 |
| Stage1-vs-Stage4 |
5.578100E-02 |
| Stage2-vs-Stage3 |
8.252000E-01 |
| Stage2-vs-Stage4 |
3.649600E-01 |
| Stage3-vs-Stage4 |
4.407600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28785870856518E-14 |
| Normal-vs-AfricanAmerican |
2.190900E-04 |
| Normal-vs-Asian |
2.24769999945806E-07 |
| Caucasian-vs-AfricanAmerican |
3.528800E-01 |
| Caucasian-vs-Asian |
7.022400E-01 |
| AfricanAmerican-vs-Asian |
5.980600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.01980662698043E-13 |
| Normal-vs-Female |
1.85251813888954E-12 |
| Male-vs-Female |
4.809200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.10520004259484E-09 |
| Normal-vs-Age(41-60Yrs) |
1.5842882561401E-13 |
| Normal-vs-Age(61-80Yrs) |
1.72062364356407E-12 |
| Normal-vs-Age(81-100Yrs) |
3.791900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.761700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.999500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.070800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.014600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.002600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.694000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.382080E-02 |
| Classical-VS-Follicular |
3.517000E-01 |
| Classical-VS-Other |
3.777600E-01 |
| Classical-VS-Normal |
7.768896637117E-12 |
| Tall-VS-Follicular |
1.475780E-01 |
| Tall-VS-Other |
8.913600E-01 |
| Tall-VS-Normal |
1.93919991176017E-10 |
| Follicular-VS-Other |
5.931200E-01 |
| Follicular-VS-Normal |
1.42080003318057E-09 |
| Other-VS-Normal |
1.761750E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65423230669148E-13 |
| Normal-vs-N1 |
5.3847999947898E-08 |
| N0-vs-N1 |
6.566400E-01 |
|
|
